Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Xianlei Li, Ph.D.

Concepts (31)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Xianlei Li's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Xianlei Li has written about over time.
Doxorubicin, 1 publications between 2018 and 2018, average publication date December 2018. Fluorescence, 1 publications between 2018 and 2018, average publication date December 2018. Gelatin, 1 publications between 2018 and 2018, average publication date December 2018. Indocyanine Green, 1 publications between 2018 and 2018, average publication date December 2018. Nanocapsules, 1 publications between 2018 and 2018, average publication date December 2018. Antineoplastic Agents, 2 publications between 2018 and 2019, average publication date January 2019. Cystamine, 1 publications between 2019 and 2019, average publication date February 2019. Hyaluronic Acid, 1 publications between 2019 and 2019, average publication date February 2019. Nanoparticles, 1 publications between 2019 and 2019, average publication date February 2019. Photochemotherapy, 1 publications between 2019 and 2019, average publication date February 2019. Tissue Distribution, 1 publications between 2019 and 2019, average publication date February 2019. Nanostructures, 1 publications between 2023 and 2023, average publication date May 2023. Hydrogels, 1 publications between 2023 and 2023, average publication date September 2023. Interleukin-6, 1 publications between 2023 and 2023, average publication date September 2023.

To see the data from this visualization as text, click here.
Li's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (31)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.